Emil D. Kakkis
Overview
Emil D. Kakkis received an average of $4M in total compensation, including $530K in salary, at Ultragenyx Pharmaceutical from 2012 to 2019.
2019Ultragenyx PharmaceuticalPresident and Chief Executive Officer
2018Ultragenyx PharmaceuticalPresident and Chief Executive Officer
2017Ultragenyx PharmaceuticalPresident and Chief Executive Officer
2016Ultragenyx PharmaceuticalPresident and Chief Executive Officer
2015Ultragenyx PharmaceuticalPresident and Chief Executive Officer
2014Ultragenyx PharmaceuticalPresident and Chief Executive Officer
2013Ultragenyx PharmaceuticalPresident and Chief Executive Officer
2012Ultragenyx PharmaceuticalPresident and Chief Executive Officer
Source: SEC filings on April 29, 2020, April 22, 2019, April 27, 2018, April 28, 2017, April 18, 2016, and May 23, 2014.
Related executives
We found nine more executives who work or worked at Ultragenyx Pharmaceutical.
John Pinion
Ultragenyx Pharmaceutical
Chief Quality Officer and Executive Vice President, Translational Sciences
Shalini Sharp
Ultragenyx Pharmaceutical
Chief Financial Officer
Camille Bedrosian
Ultragenyx Pharmaceutical
Chief Medical Officer
Thomas Kassberg
Ultragenyx Pharmaceutical
Chief Business Officer and Executive Vice President
Wladimir Hogenhuis
Ultragenyx Pharmaceutical
Chief Operating Officer
Karah Parschauer
Ultragenyx Pharmaceutical
General Counsel
Jayson Dallas
Ultragenyx Pharmaceutical
Chief Commercial Officer and Executive Vice President
Dennis Huang
Ultragenyx Pharmaceutical